Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Effectiviteit en veiligheid van rituximab bij myasthenia gravis
nov 2022 | Neuro-vasculair